New Leads for Malaria Treatment

  • ChemPubSoc Europe Logo
  • Author: ChemMedChem
  • Published Date: 21 July 2019
  • Source / Publisher: ChemMedChem/Wiley-VCH
  • Copyright: Wiley-VCH Verlag GmbH & Co. KGaA
thumbnail image: New Leads for Malaria Treatment

Related Societies

Malaria is a parasitic disease transferred by mosquitos. The species of Plasmodium falciparum is responsible for most malaria cases in Africa, and infections often lead to death. Drug resistance adds to the need for new antimalarial drugs.


Ian H. Gilbert, Kevin D. Read, both University of Dundee, UK, and colleagues, synthesized a library of 31 compounds and evaluated their antimalarial potency. As a starting point, the researchers selected an amidoacetamide from a high-throughput screening by GlaxoSmithKline for further optimization. The chosen compound showed promising antimalarial activity against P. falciparum, and was not cytotoxic for mammalian cells at concentrations tested. Modification of the linker led to a compound (pictured) with antimalarial potency that was improved more than 10-fold compared with the lead structure. It selectively inhibited P. falciparum with a half maximal effective concentration (EC50) of 7 nM.


However, the metabolic stability and solubility of the compound were still poor, and could not be improved while maintaining the antimalarial activity. According to the researchers, it is nevertheless a valuable compound for the identification of the molecular target and the search for new antimalarial drugs.


  • Substituted Aminoacetamides as Novel Leads for Malaria Treatment,
    Neil R. Norcross, Caroline Wilson, Beatriz Baragaña, Irene Hallyburton, Maria Osuna-Cabello, Suzanne Norval, Jennifer Riley, Daniel Fletcher, Robert Sinden, Michael Delves, Andrea Ruecker, Sandra Duffy, Stephan Meister, Yevgeniya Antonova-Koch, Benigno Crespo, Cristina de Cózar, Laura M. Sanz, Francisco Javier Gamo, Vicky M. Avery, Julie A. Frearson, David W. Gray, Alan H. Fairlamb, Elizabeth A. Winzeler, David Waterson, Simon F. Campbell, Paul A. Willis, Kevin D. Read, Ian H. Gilbert,
    ChemMedChem 2019, 14, 1329–1335.
    https://doi.org/10.1002/cmdc.201900329

 

Article Views: 1019

Sign in Area

Please sign in below

Additional Sign In options

Please note that to comment on an article you must be registered and logged in.
Registration is for free, you may already be registered to receive, e.g., the newsletter. When you register on this website, please ensure you view our terms and conditions. All comments are subject to moderation.

Article Comments - To add a comment please sign in

Bookmark and Share

If you would like to reuse any content, in print or online, from ChemistryViews.org, please contact us first for permission. more


CONNECT:

ChemistryViews.org on Facebook

ChemistryViews.org on Twitter ChemistryViews.org on YouTube ChemistryViews.org on LinkedIn Sign up for our free newsletter


A product of ChemPubSoc Europe (16 European Chemical Societies)and Wiley-VCH